One Innovation Labs
One Innovation Labs is a Miami-based B2B manufacturer of 250+ proprietary nutraceutical ingredients, selling LiposoMax®, PureWay-C®, and DUOCAP® delivery platforms plus custom formulation and liposomal enhancement services to nutraceutical, sports nutrition, and health & wellness brands.
- Company typePrivate
- Founded2000
- HeadquartersMiami, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What One Innovation Labs does
One Innovation Labs is a Miami-based, privately held nutraceutical ingredient manufacturer and contract formulator founded by Pedro Perez, PhD, serving nutraceutical supplement brands, sports nutrition companies, and health & wellness manufacturers on a B2B wholesale basis. The company operates a 40,000 square foot FDA-compliant manufacturing facility in Miami Lakes, FL and offers a portfolio of more than 250 premium ingredients, anchored by three proprietary technology platforms: LiposoMax®, a liposomal delivery system that encapsulates actives in microscopic lipid spheres for enhanced bioavailability (verified by Cryo-TEM imaging); PureWay-C®, a clinically backed lipid-metabolite vitamin C; and DUOCAP®, a dual-chamber capsule-in-capsule delivery system co-developed with Lonza.
The business model combines bulk ingredient sales (wholesale B2B with minimum order quantities and quote-based pricing), custom formulation R&D services (concept-to-finished-product development including ingredient sourcing and stability testing), and liposomal enhancement services (applying LiposoMax® to partners' existing formulations). Go-to-market is enterprise field sales led by a CEO, VP of Sales, and two Directors of Sales, augmented by channel partnerships with ingredient suppliers Kyowa Hakko and Prinova, capsule hardware partner Lonza, downstream brand Sports Research, and 52 industry partners in total. Demand generation runs through industry events (SupplySide Global 2025), the PricePlow Podcast, the corporate website, newsletter, and LinkedIn. The company is founder/management-owned with no disclosed institutional investment, no public revenue disclosure, and clinical validation including an Adelphi University study showing approximately 2x cellular absorption for LiposoMax creatine and 80% consumer preference for DUOCAP delivery in nationwide testing.
One Innovation Labs firmographics
Firmographics- Name
- One Innovation Labs
- Legal name
- One Innovation Labs
- Website
- https://oneinnovationlabs.com
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- One Innovation Labs is a Miami-based B2B manufacturer of 250+ proprietary nutraceutical ingredients, selling LiposoMax®, PureWay-C®, and DUOCAP® delivery platforms plus custom formulation and liposomal enhancement services to nutraceutical, sports nutrition, and health & wellness brands.
- Ownership category
- akta.pro rank
One Innovation Labs industry classification
Industry- Product category
- Nutraceutical Ingredient Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Medicinal Chemicals & Botanical Products (2833), Food And Kindred Products (2000), Miscellaneous Food Preparations & Kindred Products (2090)
- akta.pro primary industry
- Delivery Systems & Encapsulation (Microencapsulation, Liposomes, Emulsions, Beadlets, Spray-Dried) (AFAJAKAL)
- akta.pro secondary industries
- Probiotics & Digestive Health Supplements (CRADAGAF), Weight Management & Metabolic Supplements (CRADAGAG)
Keywords
Where One Innovation Labs is headquartered
LocationHeadquarters
- HQ city
- Miami
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
One Innovation Labs business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain
Revenue model
- Bulk Ingredient Sales: Wholesale B2B sales of proprietary liposomal ingredients (LiposoMax® and PureWay-C®) to nutraceutical manufacturers and brands. The company carries 250+ premium ingredients with minimum order quantities.
- Custom Formulation Services: Full-scale R&D and custom formulation services from concept to finished product. Includes ingredient sourcing, stability testing, and cutting-edge delivery methods. Science-first approach with no off-the-shelf solutions.
- Liposomal Enhancement Services: Enhancement service where the company applies their LiposoMax® technology to partner brands' existing or new products to improve bioavailability through their proprietary liposomal delivery system.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | B2B wholesale pricing for nutraceutical manufacturers |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels5 records
One Innovation Labs product offering
Product offeringCore offering
One Innovation Labs manufactures and wholesales 250+ proprietary nutraceutical ingredients to B2B supplement brands, built around two patented technology platforms: LiposoMax® liposomal delivery technology and PureWay-C® lipid-metabolite vitamin C. The company also provides professional services including custom formulation R&D (concept to finished product) and liposomal enhancement of partner brands' existing or new supplement formulations to improve bioavailability.
Product overview
One Innovation Labs is a Miami-based nutraceutical ingredient innovator offering a portfolio of 250+ ingredients centered around two proprietary technology platforms: LiposoMax® liposomal delivery technology and PureWay-C® vitamin C. The core product line consists of LiposoMax® formulations combined with various actives (CoQ10, Magnesium, Glutathione, Creatine, Curcumin, Iron, Multivitamins, Vitamin D3, Melatonin, B-Complex, Zinc, Quercetin, Omega 3) plus standalone PureWay-C® and the advanced Liposomal PureWay-C® + DUOCAP® dual-capsule system developed with Lonza. Services include Liposomal Enhancement (applying liposomal technology to existing formulations) and Custom Formulations (full-scale R&D from concept to market-ready products).
Differentiator
Problem solved
Functional benefit
Brands
- PureWay-C: A proprietary and clinically backed lipid-metabolite form of Vitamin C that offers superior absorption and retention compared to standard vitamin C forms.
- LiposoMax
- DUOCAP
Products and services
- LiposoMax® Technology
Quantifiable outcome
- Approximately 2x cellular absorption compared to standard creatine monohydrate (Adelphi University clinical research)
- +2 more outcomes
Companies that use One Innovation Labs
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles3 records
One Innovation Labs technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
One Innovation Labs partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core.
- Kyowa HakkocoreStrategic collaboration where Kyowa Hakko, a major ingredient supplier, combines their manufacturing and distribution expertise with One Innovation Labs' pharmaceutical-grade LiposoMax® liposomal delivery technology to create differentiated supplement products.
- PrinovacoreStrategic partnership with Prinova, a global ingredient supplier, to leverage One Innovation Labs' liposomal technology for creating differentiated supplement products with enhanced bioavailability.
- LonzacoreCollaboration with Lonza, a global leader in capsule delivery systems, to pioneer nutraceutical excellence with LiposoMax™ Technology and the advanced DUOCAP® dual-chamber capsule system for superior bioavailability.
- Sports ResearchcoreSports Research utilizes One Innovation Labs' LiposoMax® liposomal delivery platform to create differentiated sports nutrition supplement products with clinically proven enhanced absorption.
- Adelphi UniversitycoreAcademic research partnership conducting clinical studies validating liposomal technology efficacy. Adelphi University research demonstrated approximately double the cellular absorption for LiposoMax® creatine compared to standard creatine monohydrate.
- 52 Industry PartnerscoreThe company is associated with 52 partners in advancing next-generation liposomal development, representing strategic collaborations across the nutraceutical supply chain.
Scale indicators6 records
Recent moves2 records
Expansion highlights6 records
One Innovation Labs competitors and assessment
Company assessmentBroad incumbents
- Gencor: Gencor is a global branded-ingredient supplier serving nutraceutical manufacturers with clinically validated actives and proprietary delivery technologies. Operates in the same B2B ingredient space with similar go-to-market targeting supplement brands seeking differentiated, science-backed ingredients.
- FutureCeuticals: FutureCeuticals is a vertically integrated specialty ingredient manufacturer producing branded botanical, fruit, and vegetable ingredients for supplement and food manufacturers. Comparable in serving B2B nutraceutical customers with proprietary, science-supported ingredients from owned manufacturing.
- AIDP Inc. AIDP is a value-added distributor and developer of branded specialty ingredients (including liposomal and pre-formed mineral formats) for the nutraceutical industry. Comparable B2B ingredient-platform model, with overlap on liposomal delivery formats and a similar customer base of supplement brands.
- PLT Health Solutions: PLT Health Solutions is a specialty ingredient platform offering branded, clinically researched ingredients to nutraceutical and functional food manufacturers. Comparable business model — proprietary science-backed ingredients sold B2B to brands seeking differentiation — though with a wider and more mature portfolio of branded actives.
- Sabinsa: Sabinsa is a large, established specialty ingredient manufacturer supplying branded extracts and delivery-formatted ingredients (including liposomal formats) to nutraceutical brands globally. Comparable in serving the same B2B customer base with proprietary science-backed ingredients, but at substantially larger scale and broader portfolio breadth than One Innovation Labs.
- Nutrition21: Nutrition21 is a branded ingredient supplier focused on clinically validated mineral and trace-element actives (e.g., Chromax, Nitrosigine) for the nutraceutical industry. Operates in the same specialty-ingredient B2B space serving supplement brands seeking proprietary, science-backed differentiators.
Emerging players
- Applied Food Sciences: Applied Food Sciences is a specialty botanical and functional ingredient supplier serving beverage and supplement manufacturers with proprietary, research-backed ingredients. Comparable B2B specialty-ingredient model with similar science-first positioning, though smaller and less delivery-platform focused than One Innovation Labs.
- Stratum Nutrition: Stratum Nutrition is a specialty ingredient supplier offering branded, science-backed nutraceutical ingredients to manufacturers and brand owners. Comparable B2B ingredient-distribution model with proprietary technology positioning, though smaller in scale and focused on a narrower ingredient portfolio than One Innovation Labs.
Direct peers
- Lipocine: Lipocine is a specialty pharmaceutical company developing lipid-based drug delivery technologies, including liposomal platforms, for improved bioavailability. While primarily pharma-focused, the underlying lipid-encapsulation technology and delivery science are highly comparable to One Innovation Labs' LiposoMax® platform.
- Quicksilver Scientific: Quicksilver Scientific is a closely comparable liposomal delivery company offering nano-encapsulated liposomal supplements and ingredient technologies. Like One Innovation Labs, it focuses on bioavailability enhancement through proprietary lipid-based delivery systems, making it the most direct technical and category peer.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks3 records
Key highlights6 records
Customer concentration
One Innovation Labs social profiles
Digital presenceOne Innovation Labs financial estimates
Financial estimateRevenue estimate
Valuation estimate
One Innovation Labs leadership team
Management profileNumber of profiles
Profiles7 records
One Innovation Labs funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
One Innovation Labs M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about One Innovation Labs
What does One Innovation Labs do?
One Innovation Labs manufactures and wholesales 250+ proprietary nutraceutical ingredients to B2B supplement brands, built around two patented technology platforms: LiposoMax® liposomal delivery technology and PureWay-C® lipid-metabolite vitamin C. The company also provides professional services including custom formulation R&D (concept to finished product) and liposomal enhancement of partner brands' existing or new supplement formulations to improve bioavailability.
Is One Innovation Labs a public or private company?
One Innovation Labs is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was One Innovation Labs founded?
One Innovation Labs was founded in 2000. It employs 11 to 50 people.
Where is One Innovation Labs based?
One Innovation Labs is headquartered in Miami, United States, in the North America region.
How does One Innovation Labs make money?
Three revenue lines are on record. Bulk Ingredient Sales are the primary driver. The others are custom Formulation Services and liposomal Enhancement Services.
Who are One Innovation Labs's main competitors?
Broad incumbents on record are Gencor, FutureCeuticals, AIDP Inc., PLT Health Solutions, Sabinsa and Nutrition21. Emerging players are Applied Food Sciences and Stratum Nutrition. Direct peers are Lipocine and Quicksilver Scientific.
Does One Innovation Labs have an API?
No public API is recorded for One Innovation Labs.
What industry is One Innovation Labs in?
One Innovation Labs's product category is Nutraceutical Ingredient Manufacturing. Its primary akta.pro industry code is AFAJAKAL, Delivery Systems & Encapsulation (Microencapsulation, Liposomes, Emulsions, Beadlets, Spray-Dried), with a secondary code of CRADAGAF, Probiotics & Digestive Health Supplements. Its NAICS code is 325412 and its SIC code is 2833.